Racial/Ethnic Differences in Pediatric Brain Tumor Diagnoses in Patients with Neurofibromatosis Type 1

Journal of Pediatrics

Volumn 167, Issue 3, 2015, Pages 613-620.e2

  Abadin, Salmafatima S ^a   Zoellner, Nancy L ^a   Schaeffer, Melody ^a   Porcelli, Bree ^b   Gutmann, David H ^b   Johnson, Kimberly J ^a,b  

^a WASHINGTON UNIVERSITY IN ST LOUIS   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASIAN; BLACK PERSON; BRAIN TUMOR; CANCER PATIENT; CAUCASIAN; CROSS-SECTIONAL STUDY; DATA BASE; ETHNIC DIFFERENCE; FEMALE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROFIBROMATOSIS TYPE 1; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; BRAIN NEOPLASMS; CHILD; ETHNIC GROUP; ETHNOLOGY; NEUROFIBROMATOSIS 1; REGISTER; STATISTICAL MODEL;

BRAIN NEOPLASMS; CHILD; CROSS-SECTIONAL STUDIES; ETHNIC GROUPS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; NEUROFIBROMATOSIS 1; REGISTRIES;

EID: 84940447015     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2015.04.076     Document Type: Article

References (37)

1. E. Uusitalo, J. Leppavirta, A. Koffert, S. Suominen, J. Vahtera, T. Vahlberg, and et al. Incidence and mortality of neurofibromatosis: a total population study in Finland J Invest Dermatol 135 2015 904 906
2. L. Walker, D. Thompson, D. Easton, B. Ponder, M. Ponder, I. Frayling, and et al. A prospective study of neurofibromatosis type 1 cancer incidence in the UK Br J Cancer 95 2006 233 238
3. S.A. Rasmussen, Q. Yang, and J.M. Friedman Mortality in neurofibromatosis 1: an analysis using U.S. death certificates Am J Hum Genet 68 2001 1110 1118
4. T.A. Duong, E. Sbidian, L. Valeyrie-Allanore, C. Vialette, S. Ferkal, S. Hadj-Rabia, and et al. Mortality associated with neurofibromatosis 1: a cohort study of 1895 patients in 1980-2006 in France Orphanet J Rare Dis 6 2011 18
5. O.O. Seminog, and M.J. Goldacre Risk of benign tumours of nervous system, and of malignant neoplasms, in people with neurofibromatosis: population-based record-linkage study Br J Cancer 108 2013 193 198
6. B.W. Scheithauer, S. Erdogan, F.J. Rodriguez, P.C. Burger, J.M. Woodruff, J.M. Kros, and et al. Malignant peripheral nerve sheath tumors of cranial nerves and intracranial contents: a clinicopathologic study of 17 cases Am J Surg Pathol 33 2009 325 338
7. G.E. Airewele, A.J. Sigurdson, K.J. Wiley, B.E. Frieden, L.W. Caldarera, V.M. Riccardi, and et al. Neoplasms in neurofibromatosis 1 are related to gender but not to family history of cancer Genet Epidemiol 20 2001 75 86
8. S.L. Hyman, E. Arthur Shores, and K.N. North Learning disabilities in children with neurofibromatosis type 1: subtypes, cognitive profile, and attention-deficit-hyperactivity disorder Dev Med Child Neurol 48 2006 973 977
9. S.L. Hyman, A. Shores, and K.N. North The nature and frequency of cognitive deficits in children with neurofibromatosis type 1 Neurology 65 2005 1037 1044
10. V.F. Mautner, L. Kluwe, S.D. Thakker, and R.A. Leark Treatment of ADHD in neurofibromatosis type 1 Dev Med Child Neurol 44 2002 164 170
11. S. Garg, E. Plasschaert, M.J. Descheemaeker, S. Huson, M. Borghgraef, A. Vogels, and et al. Autism spectrum disorder profile in neurofibromatosis type I J Autism Dev Disord 2014 Dec 5. [Epub ahead of print]
12. E. Plasschaert, M.J. Descheemaeker, L. Van Eylen, I. Noens, J. Steyaert, and E. Legius Prevalence of autism spectrum disorder symptoms in children with neurofibromatosis type 1 Am J Med Genet B Neuropsychiatr Genet 168B 2015 72 80
13. J.M. Friedman, J. Arbiser, J.A. Epstein, D.H. Gutmann, S.J. Huot, A.E. Lin, and et al. Cardiovascular disease in neurofibromatosis 1: report of the NF1 Cardiovascular Task Force Genet Med 4 2002 105 111
14. T.L. Rosser, G. Vezina, and R.J. Packer Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1 Neurology 64 2005 553 555
15. D. Viskochil Genetics of neurofibromatosis 1 and the NF1 gene J Child Neurol 17 2002 562 570 discussion 71-2, 646-51
16. J.S. Guillamo, A. Creange, C. Kalifa, J. Grill, D. Rodriguez, F. Doz, and et al. Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): a retrospective study of 104 patients Brain 126 2003 152 160
17. D.H. Gutmann, S.A. Rasmussen, P. Wolkenstein, M.M. MacCollin, A. Guha, P.D. Inskip, and et al. Gliomas presenting after age 10 in individuals with neurofibromatosis type 1 (NF1) Neurology 59 2002 759 761
18. A.C. Albers, and D.H. Gutmann Gliomas in patients with neurofibromatosis type 1 Expert Rev Neurother 9 2009 535 539
19. Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference Arch Neurol 45 1988 575 578
20. R.E. Ferner, S.M. Huson, N. Thomas, C. Moss, H. Willshaw, D.G. Evans, and et al. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1 J Med Genet 44 2007 81 88
21. M.A. Blazo, R.A. Lewis, M.M. Chintagumpala, M. Frazier, C. McCluggage, and S.E. Plon Outcomes of systematic screening for optic pathway tumors in children with Neurofibromatosis Type 1 Am J Med Genet A 127A 2004 224 229
22. S.C. Kaste, and E.K. Pivnick Bony orbital morphology in neurofibromatosis type 1 (NF1) J Med Genet 35 1998 628 631
23. A. King, R. Listernick, J. Charrow, L. Piersall, and D.H. Gutmann Optic pathway gliomas in neurofibromatosis type 1: the effect of presenting symptoms on outcome Am J Med Genet A 122A 2003 95 99
24. B.A. Pletcher, M.I. Magee, L.P. Frohman, R.S. Wagner, P. DeRespinis, S. Kamin, and et al. Confirmation of decreased risk of optic glioma in African Americans with NF type 1 [Abstract] Am J Hum Genet 59 1996 A101
25. H.M. Saal, E.K. Schorry, A.M. Lovell, W. Ball, J. Egelhoff, B. Koch, and et al. Racial differences in the prevalence of optic nerve gliomas in neurofibromatosis type 1 [Abstract] Am J Hum Genet 57 1995 280
26. K.J. Johnson, I. Hussain, K. Williams, R. Santens, N.L. Mueller, and D.H. Gutmann Development of an international internet-based neurofibromatosis type 1 patient registry Contemp Clin Trials 34 2013 305 311
27. K.J. Johnson, N.L. Mueller, K. Williams, and D.H. Gutmann Evaluation of participant recruitment methods to a rare disease online registry Am J Med Genet A 164 2014 1686 1694
28. E.K. Sharkey, N.L. Zoellner, S. Abadin, D.H. Gutmann, and K.J. Johnson Validity of participant-reported diagnoses in an online patient registry: a report from the NF1 Patient Registry Initiative Contemp Clin Trials 40C 2014 212 217
29. A.P. Ostendorf, D.H. Gutmann, and J.L. Weisenberg Epilepsy in individuals with neurofibromatosis type 1 Epilepsia 54 2013 1810 1814
30. R.S. Cooper Race in biological and biomedical research Cold Spring Harb Perspect Med Nov 1;3(11) 2013
31. K.J. Johnson, J. Cullen, J.S. Barnholtz-Sloan, Q.T. Ostrom, C.E. Langer, M.C. Turner, and et al. Childhood brain tumor epidemiology: a brain tumor epidemiology consortium review Cancer Epidemiol Biomarkers Prev 23 2014 2716 2736
32. S. Sharif, M. Upadhyaya, R. Ferner, E. Majounie, A. Shenton, M. Baser, and et al. A molecular analysis of individuals with neurofibromatosis type 1 (NF1) and optic pathway gliomas (OPGs), and an assessment of genotype-phenotype correlations J Med Genet 48 2011 256 260
33. A. Bolcekova, M. Nemethova, A. Zatkova, K. Hlinkova, S. Pozgayova, A. Hlavata, and et al. Clustering of mutations in the 5' tertile of the NF1 gene in Slovakia patients with optic pathway glioma Neoplasma 60 2013 655 665
34. H. Xu, C. Cheng, M. Devidas, D. Pei, Y. Fan, W. Yang, and et al. ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia J Clin Oncol 30 2012 751 757
35. H. Xu, W. Yang, V. Perez-Andreu, M. Devidas, Y. Fan, C. Cheng, and et al. Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations J Natl Cancer Inst 105 2013 733 742
36. G. Flores Committee On Pediatric Research Technical report - racial and ethnic disparities in the health and health care of children Pediatrics 125 2010 e979 e1020
37. United States Cancer Statistics: 1999-2011 Incidence, WONDER Online Database 2014 United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute http://wonder.cdc.gov/cancer-v2011.html Accessed on February 5, 2015